Related Experiment Video
Updated: Jan 10, 2026

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast
Published on: January 26, 2017
Continuous targeted hypermutation with a tunable mutation window
Chanwoo Lee1, Seokhee Kim2,3
1Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
Abstract:
Targeted in vivo hypermutation drives rapid sequence diversification within specific DNA regions of living cells, enabling continuous evolution of biomolecules for enhanced functionality. In living organisms, this is prominently illustrated by the preferential somatic hypermutation of complementarity-determining regions during antibody affinity maturation. This particular targeting strategy employs focused mutagenesis in predefined, functionally important intragenic regions and should ideally allow for target range adjustment to support broader applications. However, molecular tools incorporating these features remain limited. Here, we present RESPECTevo, a system for focused hypermutation of endogenous and heterologous regions up to ~200 bp with predefined boundaries. By leveraging specific targeting capability, spacer length flexibility, and mismatch tolerance of the Escherichia coli Cascade complex, RESPECTevo enables highly specific targeted hypermutation, target range modulation, and continuous hypermutation across dual regions. Collectively, RESPECTevo serves as an efficient platform for hypermutating user-defined target regions in living cells, facilitating continuous protein evolution for biotechnological applications.
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Spontaneous and Induced Mutations
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
In-vitro Mutagenesis
Targeted Cancer Therapies
There are several types of targeted therapies against...

